Hsieh, J. C., Chiang, P., Hung, T., Chao, Y., Kuo, Y., Wen, C., . . . Wang, H. (2021). Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence. Wiley.
Style de citation Chicago (17e éd.)Hsieh, Jason Chia‐Hsun, et al. Definitive Concurrent Chemoradiotherapy with Paclitaxel Plus Carboplatin Is Superior to Cisplatin Plus 5‐fluorouracil in Patients with Inoperable Esophageal Squamous Cell Carcinoma Using Retrospective, Real‐world Evidence. Wiley, 2021.
Style de citation MLA (8e éd.)Hsieh, Jason Chia‐Hsun, et al. Definitive Concurrent Chemoradiotherapy with Paclitaxel Plus Carboplatin Is Superior to Cisplatin Plus 5‐fluorouracil in Patients with Inoperable Esophageal Squamous Cell Carcinoma Using Retrospective, Real‐world Evidence. Wiley, 2021.